{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T21:04:05Z","timestamp":1778447045803,"version":"3.51.4"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12028-024-02171-3","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T18:31:08Z","timestamp":1733164268000},"page":"726-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Case of Guillain\u2013Barr\u00e9 Syndrome and Repurposing cEEG to Enable Communication in Total Locked-in Syndrome"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8432-113X","authenticated-orcid":false,"given":"Thomas J.","family":"Pisano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"issue":"9","key":"2171_CR1","volume":"2014","author":"RA Hughes","year":"2014","unstructured":"Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2014;2014(9): CD002063.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2171_CR2","volume":"2017","author":"S Chevret","year":"2017","unstructured":"Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2017;2017(2): CD001798.","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"2171_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FG van der Mech\u00e9","year":"1992","unstructured":"van der Mech\u00e9 FG, Schmitz PI, Dutch Guillain\u2013Barr\u00e9 Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. N Engl J Med. 1992;326(17):1123\u20139.","journal-title":"N Engl J Med"},{"issue":"9047","key":"2171_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","unstructured":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain\u2013Barr\u00e9 syndrome. Lancet. 1997;349(9047):225\u201330.","journal-title":"Lancet"},{"key":"2171_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2023.100468","volume":"31","author":"HA Zaki","year":"2023","unstructured":"Zaki HA, Iftikhar H, Najam M, Masood M, Al-Marri ND, Elgassim MA, et al. Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain\u2013Barr\u00e9 syndrome (GBS) in patients with severe symptoms: a systematic review and meta-analysis. eNeurologicalSci. 2023;31: 100468.","journal-title":"eNeurologicalSci"},{"issue":"10","key":"2171_CR6","volume":"2016","author":"RA Hughes","year":"2016","unstructured":"Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain\u2013Barr\u00e9 syndrome. Cochrane Database Syst Rev. 2016;2016(10): CD001446.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2171_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF00313105","volume":"221","author":"G Bauer","year":"1979","unstructured":"Bauer G, Gerstenbrand F, Rumpl E. Varieties of the locked-in syndrome. J Neurol. 1979;221(2):77\u201391.","journal-title":"J Neurol"},{"issue":"6","key":"2171_CR8","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/WCO.0b013e328315ee2d","volume":"21","author":"N Birbaumer","year":"2008","unstructured":"Birbaumer N, Murguialday AR, Cohen L. Brain-computer interface in paralysis. Curr Opin Neurol. 2008;21(6):634\u20138.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"2171_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12984-023-01272-y","volume":"20","author":"E Canny","year":"2023","unstructured":"Canny E, Vansteensel MJ, van der Salm SM, M\u00fcller-Putz GR, Berezutskaya J. Boosting brain-computer interfaces with functional electrical stimulation: potential applications in people with locked-in syndrome. J Neuroeng Rehabil. 2023;20(1):157.","journal-title":"J Neuroeng Rehabil"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-024-02171-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02171-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T16:21:08Z","timestamp":1743351668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-024-02171-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["2171"],"URL":"https:\/\/doi.org\/10.1007\/s12028-024-02171-3","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no potential conflicts of interest relevant to this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This study is in accordance with the principles of the Institutional Review Board (IRB) of the University of Pennsylvania that a case report of three or less cases does not require IRB approval (3.2.2). The patient consented for their case to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}